Memphis, Tennessee news: UC researchers pioneering research to treat 'brain tsunamis'
University of Cincinnati researchers are enrolling patients in a first-of-its-kind trial that tests a treatment for abnormal brain activity sometimes referred to as a “brain tsunami.”
The phenomenon is officially called a spreading depolarization (SD). UC’s Jed Hartings, PhD, principal investigator of the trial, explained that just like a battery, brain cells have a stored, or polarized, charge that enables them to send electrical signals to each other.
During SD, the brain cells lose their charge, becoming depolarized and unable to send electrical signals to each other.
“We’re finding out it is a likely culprit in more and more diseases than we ever thought imaginable. It’s kind of like the hidden iceberg below the surface,” Hartings, professor and vice chair of research in the Department of Neurosurgery in UC’s College of Medicine, told Memphis, Tennessee television station Action News 5.
There is no current standard of care to treat SD, and in the trial, an electrode strip is placed in patients' brains to monitor activity. Neurocritical care experts like Laura Ngwenya, MD, PhD, can then more closely manage blood pressure, blood sugar and body temperature or administer the drug ketamine to stop SDs.
"This has actually been revolutionary, in terms of how we think about how we treat brain injury patients,” Ngwenya, associate professor and director of neurotrauma in the Department of Neurosurgery in UC’s College of Medicine, told Action News 5.
Watch or read the Action News 5 story.
Featured photo at top of neurons. Photo/Imaginima/iStock.
Related Stories
CCM welcomes new film and media scoring faculty member J.R. Paredes
May 20, 2026
UC College-Conservatory of Music Dean Pete Jutras has announced the appointment of J.R. Paredes as CCM's new Assistant Professor of Film and Media Scoring. His faculty appointment officially begins on Aug. 15, 2026. Paredes is a composer, music producer and audio post-production specialist whose work spans film, television and commercial music. His credits include original scores for feature films and series distributed on platforms such as Apple TV+ and Prime Video, as well as extensive work in sound design and mixing for film and media.
6 ways starting a GLP-1 medication could affect your emotions
May 20, 2026
When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.